Evidence map›Paper›PMID 36076963›Full record

ArticleInternational journal of molecular sciences2022

Polysialic Acid Sustains the Hypoxia-Induced Migration and Undifferentiated State of Human Glioblastoma Cells.

Paolo Rosa, Sofia Scibetta, Giuseppe Pepe, Giorgio Mangino, Luca Capocci, Sam J Moons, Thomas J Boltje, Francesco Fazi, Vincenzo Petrozza, Alba Di Pardo and 2 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Sialylation Inhibition Impairs Migration and Promotes Adhesion of GBM Cells.International journal of molecular sciences · 2025
    Article
  3. Article
  4. Review
  5. Life (Basel, Switzerland) · 2024
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Paolo RosaDepartment of Medical-Surgical Sciences and Biotechnologies, University of Rome "Sapienza", Polo Pontino, C.so della Repubblica 79, 04100 Latina, Italy.ORCID 0000-0002-8468-0677
Sofia ScibettaDepartment of Medical-Surgical Sciences and Biotechnologies, University of Rome "Sapienza", Polo Pontino, C.so della Repubblica 79, 04100 Latina, Italy.
Giuseppe PepeIRCCS Neuromed, Via Dell'Elettronica, 86077 Pozzilli, Italy.
Giorgio ManginoDepartment of Medical-Surgical Sciences and Biotechnologies, University of Rome "Sapienza", Polo Pontino, C.so della Repubblica 79, 04100 Latina, Italy.ORCID 0000-0002-8950-9780
Luca CapocciIRCCS Neuromed, Via Dell'Elettronica, 86077 Pozzilli, Italy.
Sam J MoonsInstitute for Molecules and Materials, Radboud University, Heyendaalseweg 135, 6525 AJ Nijmegen, The Netherlands.ORCID 0000-0001-5507-3811
Thomas J BoltjeInstitute for Molecules and Materials, Radboud University, Heyendaalseweg 135, 6525 AJ Nijmegen, The Netherlands.
Francesco FaziDepartment of Anatomical, Histological, Forensic & Orthopedic Sciences, Section of Histology & Medical Embryology, University of Rome "Sapienza", Via A. Scarpa, 14-16, 00161 Rome, Italy.ORCID 0000-0003-2910-7912
Vincenzo PetrozzaDepartment of Medical-Surgical Sciences and Biotechnologies, University of Rome "Sapienza", Polo Pontino, C.so della Repubblica 79, 04100 Latina, Italy.ORCID 0000-0001-9837-8690
Alba Di PardoIRCCS Neuromed, Via Dell'Elettronica, 86077 Pozzilli, Italy.
Vittorio MaglioneIRCCS Neuromed, Via Dell'Elettronica, 86077 Pozzilli, Italy.
Antonella CalogeroDepartment of Medical-Surgical Sciences and Biotechnologies, University of Rome "Sapienza", Polo Pontino, C.so della Repubblica 79, 04100 Latina, Italy.
Istituto Neurologico Mediterraneo · ITSapienza University of Rome · ITIstituto Ortopedico Rizzoli · ITRadboud University Nijmegen · NL

Funding

Sapienza University of Rome AR22117A583BC114
6 · The paper itself

Abstract

Gliomas are the most common primary malignant brain tumors. Glioblastoma, IDH-wildtype (GBM, CNS WHO grade 4) is the most aggressive form of glioma and is characterized by extensive hypoxic areas that strongly correlate with tumor malignancy. Hypoxia promotes several processes, including stemness, migration, invasion, angiogenesis, and radio- and chemoresistance, that have direct impacts on treatment failure. Thus, there is still an increasing need to identify novel targets to limit GBM relapse. Polysialic acid (PSA) is a carbohydrate composed of a linear polymer of α2,8-linked sialic acids, primarily attached to the Neural Cell Adhesion Molecule (NCAM). It is considered an oncodevelopmental antigen that is re-expressed in various tumors. High levels of PSA-NCAM are associated with high-grade and poorly differentiated tumors. Here, we investigated the effect of PSA inhibition in GBM cells under low oxygen concentrations. Our main results highlight the way in which hypoxia stimulates polysialylation in U87-MG cells and in a GBM primary culture. By lowering PSA levels with the sialic acid analog, F-NANA, we also inhibited GBM cell migration and interfered with their differentiation influenced by the hypoxic microenvironment. Our findings suggest that PSA may represent a possible molecular target for the development of alternative pharmacological strategies to manage a devastating tumor like GBM.

Indexed as

GlioblastomaNeuroblastomaHumansHypoxiaNeoplasm Recurrence, LocalNeural Cell Adhesion MoleculesSialic AcidsTumor MicroenvironmentNeural Cell Adhesion Moleculespolysialic acidSialic Acidsdifferentiationglioblastomahypoxiamigrationpolysialic acid

Identifiers

PMID36076963
PMCPMC9455737
OpenAlexW4292999153

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.